In this session, facilitated by the Australian Injecting & Illicit Drug Users League (AIVL), we will discuss what needs to be included in the national research agenda to support better outcomes for the Australian community of people who use drugs (PWUD).
Information For People On Opioid Treatment: Methadone, Suboxone, Subutex, & Buprenorphine Injections
Information about changes from July 1 2023 to the Opioid Treatment Program across Australia.
Online Event: AIVL Consumers Forum: All your questions about changes to opioid dependence medications answered
This online event is for people on or interested in Opioid Dependence Treatment in Australia. We will discuss all the upcoming changes, and what they mean for people currently on Opioid Dependence Treatment, there will be also be a Q&A.
Online Event: Changes to the Opioid Dependence Treatment program: implications for access and transitional arrangements from 1 July 2023
AADC and AIVL joint online event, to discuss changes to the Opioid Dependence Treatment program prior to implementation.
Media Release: Australian Stigma Conference – dismantling stigma to save lives
The Australian Injecting & Illicit Drug Users League (AIVL) was first incorporated as an association in 1992. The Australian Stigma Conference is a historic milestone, celebrating 30 years of AIVL, an organisation that remains at the forefront of the response to the HIV epidemic in Australia. This response has saved many lives by limiting the spread of HIV Aids among …
Check out the livestream of AIVL’s Australian Stigma Conference!
Watch the video here: https://www.facebook.com/AIVLInc/videos/495570829203545 Today’s conference brings together policymakers, healthcare professionals and people who use drugs to discuss how stigma impacts people who use drugs. You can get your questions and comments into the conversation by using Slido! Go to slido.com and then use the code #AIVLSTIGMA22 To see the Conference Program Schedule go to aivl.org.au/events/australian-stigma-conference AIVL is the …
International Drug Users Day 2022
November 1 marks International Drug Users Day (IDUD). Held annually, the day remembers the movements and protests against the significant lack of and access to treatments and services for people who use drugs (PWUD); particularly in terms of inadequate public health policy and response to the disproportionate rates of blood borne viruses such as hepatitis and HIV amongst communities of …
AIVL and CAHMA at the 27th Annual Remembrance Ceremony for those who lose their life to illicit drugs
On a cold and wet Monday afternoon, AIVL Policy & Project Officer Adrian Gorringe braced the wild weather and joined staff from CAHMA to attend the Family and Friends For Drug Law Reform (FFDLR) (ACT) 27th Annual Remembrance Ceremony. Bill Bush, president of the ACT Chapter of FFDLR opened the event to a considerable turnout. Despite the weather, people, families, and …
WORLD FIRST AS A NEW SYNTHETIC DRUG IDENTIFIED BY CanTEST
There is a new drug circulating around Canberra! One reporter claims it may be so novel, there’s a high chance it has not even seen the inside of Berlin’s Berghain Nightclub yet. A new compound, described as “Canberra Ketamine” or “CanKet” has been identified by CanTEST; the ‘face to face’, fixed site drug testing facility based in the ACT. The lead …
The decline of meth and the rise of phenyl-2-propanone (P2P)
“I don’t know that I would even call it meth anymore…” – Joe Bozenko, DEA Chemist & Professor, Shephard University.Methamphetamine is arguably the most demonised, stigmatised and generally misconceived drug in global circulation. Within the Australian context, we have all seen the confronting, graphic and gratuitously violent imagery of anti-ice advertisements, depicting ‘ice’ users in diabolical fits of rage lashing …
Drugs in sport: dissecting the untold harms of stigmatisation.
Aussies love their stimulants nearly as much as sports! We punch well above our weight on the international level. On the world stage, we just miss out on a podium finish for our average total stimulant consumption, securing 4th place at 59 doses per 1,000 people per day [following Czechia (76 doses), the United States of America (USA; 74 doses), …
International Overdose Awareness Day – 2022
International Overdose awareness day was initiated in 2001, August 31 will mark 21 years of the world’s largest annual campaign to end overdose and remember without stigma those who have died, acknowledging the grief of all those impacted by overdose, whose loved ones have died or suffered permanent injury.
Introducing DULF
DULF is a collective made up of two drug users and activists fighting against the prevailing system that stigmatizes and kills drug users. They figuratively want to burn down the existing system, replacing it with a more caring and compassionate model. Their logo of flames encircled by flames suggests they want to be at the centre of something volatile and explosive.
CanTest Drug checking service – A much needed public health response to the overdose crisis
Thursday July 21s saw the grand opening of CanTest, Australia’s first fixed-site drug checking service, often dubbed ‘pill testing’. The service is delivered by Directions Health Services in partnership with AIVL member organisation CAHMA and Pill Testing Australia.
World Hepatitis Day- Message delivered by AIVL’s Ceo at Parliament house
AIVL and the important network of community-led organisations working in response to Blood Borne Viruses and sexually transmissible infections have, for decades utilised their limited resources to work in close partnership with each other. Not only have they been the voice of the community at a national level but have also been drivers for getting the community to both engage in healthcare and promote the uptake of harm reduction practices. We remain closely knit in our joint commitment to eliminate Hepatitis C by 2030.
AIVL’s annual World Hepatitis Day Oration
Whenever there are highly desirable restricted products within society, there will be people willing to produce, and sell “knock-offs” of the products. It doesn’t matter if it is a Gucci handbag, concert tickets, or a pill. Within the drug using community, it is becoming more common for the “People’s Choice” of benzos (Xanax) to be mimicked and sold by “bootleggers.”
International Drug Users Remembrance Day – 2022
21 July marks the date of International Drug Users Remembrance Day, a day observed by the International Network of People who use Drugs (INPUD) in conjunction with UNAIDS, to reflect upon the countless lives lost to drug related harm.
Overdosing is Not a Crime! Neither is Harm Reduction Education and Information.
Whenever there are highly desirable restricted products within society, there will be people willing to produce, and sell “knock-offs” of the products. It doesn’t matter if it is a Gucci handbag, concert tickets, or a pill. Within the drug using community, it is becoming more common for the “People’s Choice” of benzos (Xanax) to be mimicked and sold by “bootleggers.”
AIVL at ‘Support Don’t Punish: Is it time to legalise drugs?’
Last month AIVL Staff attended ‘Is it time to legalise drugs?’ a discussion by Drug Policy Australia on Friday June 24. Presentations by Dr Alex Wodak, Dr Annie Madden AO, The Honourable Michael Kirby, The Honourable Bob Carr, Greg Chipp and Emma Maiden covered topics of the harms of illicit drug criminalisation, drug law reform, and the need for drug policies to be viewed within a public health lens, stating that our current drug policies are not assessed on merit but rather cultural and societal ‘norms’, characterised by moralistic righteousness against the backdrop of maintaining diplomatic ties through the established rhetoric of prohibition politics.
The Juice – Information For Safer Gains
Hepatitis Australia and the Australian Injecting & Illicit Drug Users League (AIVL) is proud to announce that there is now a dedicated resource for people who use performance and image enhancing drugs (PIEDs).
Party and Play: Sex, drugs, gender diversity and perceptions of overdose- Praise for Jack Freestone et al (2022) GHB article
AIVL praises Freestone et al. for the ingenuity of their research that has shed light upon some of the lesser understood scenes associated with recreational drug use, and the role of harm reduction, peer networks and ever apparent need for education around overdose and BBV/STI risks surrounding chemsex.
Overdose is a National Crisis – AIVL urges the Albanese Government to take this issue seriously
Almost 1700 Australians die of illicit drug overdoses each year. These are peoples’ sons, daughters, brothers, sisters, neighbours, and friends.
It’s Your Right Campaign – Live Free of Hep C
The elimination of hepatitis C in a priority group, people who inject drugs, is the goal of a new campaign to be rolled out across Australia over the coming months.
MSIC: 21 Years Of Saving Lives
AIVL has raised concerns about the statutory price reduction of slow-release buprenorphine and the potential impact this may have on people who choose MATOD treatment for Opioid Dependence.
Federal Election 2022: We hope for a better future for People Who Use Drugs
With the public view on drug use shifting fast, AIVL would like the elected government in this federal election 2022 to take a more pragmatic and Peer consultative approach while creating policies that affect PWUD
Ministerial Discretion may be the only solution to ensure MATOD medicine choice
AIVL has raised concerns about the statutory price reduction of slow-release buprenorphine and the potential impact this may have on people who choose MATOD treatment for Opioid Dependence.
The Federal Government is putting a Spotlight on Overdose- but is it enough?
Media Release by Jake Docker: Australian Budget 2022-23
Vein Care guide – Animated Explainer videos
Designed to enhance understanding between people who use drugs and healthcare professionals.
Bulletin: How are people assisted with their first injecting experience, and what information do they receive prior?
How are people assisted with their first injecting experience, and what information do they receive prior? A review of the literature suggests that peer workforces should be expanded and receive more support
Australia’s Opioid Crisis and barriers to access essential medicine
Around 900 people die of opioid-related overdose in Australia each year. Opioid Treatment (OT) can protect against opioid overdose. When will governments in Australia take this seriously and widen access to OT?!
AIVL CEO, Jake Docker on 2XX FM: ‘News From the Drug War Front’
Jake speaks about how stigma & discrimination significantly impact the ability of PWUD to access health, support services and experience a sense of recognition in a society that continues to discriminate against PWUD.
Fentanyl: History, Society & Harm-reduction
This article provides succinct incites on fentanyl, as a medicine, a new drug-related to online drug markets, and a reason to invest more (not less) in community-led harm reduction initiatives.
Increasing Harm: The Dangers of Sniffer Dog Operations
AIVL calls for the government to prioritise human lives.
A place of their own
Designed to enhance understanding between people who use drugs and healthcare professionals.
Australian harm reduction measures only ‘moderately adequate’
Australia ranks relatively highly in the new Global Policy Index. But that ranking flatters Australia’s harm reduction efforts.
National Health Amendment Bill 2021: More transparency and community consultation needed
AIVL calls on Parliament to allow for greater consultation before the PBS Bill 2021 is passed.
Afternoons with Max Marshall
A short movie AIVL produced to tackle the subject of stigma in the workplace.
World Aids Day 2021: We pay tribute to our predecessors
This World AIDS Day (1 December 2021), AIVL is honouring the work of all those who came before us.
Missing Connections
Service user experiences of people living with hepatitis C exiting custodial settings.
Hidden Harms
Focuses on meth use and routes of transmission of blood borne viruses and sexually transmissible infections.
Methamphetamine use and Blood Borne Virus/Sexually Transmissible Infection (BBV/STI)
This resource provides key information on methamphetamine use in relation to BBVs and STIs.
Interim guidance for the delivery of medication-assisted treatment of opioid dependence in response to COVID-19: A national response
Delivery of medication-assisted treatment of opioid dependence in response to COVID-19.
A Hidden Population
Aims to build capacity within aged care providers to respond to the unique needs of older people.
Renewed calls for NSPs in prisons ahead of Drug Users Day
AIVL and Hepatitis Australia highlight international calls for NSPs in prisons, along with a greater focus on harm reduction initiatives.
A framework for peer education by drug-user organisations
The AIVL Peer Education Framework is a starting point for understanding our approach to peer education.
No one likes using the dirties – A study into the re-use of injecting equipment in Australia
Contains the findings of a peer-based qualitative research study into the re-use of injecting equipment.
No significant BBV/STI or AOD measures in Health Budget
AIVL has expressed disappointment there is little evidence of new investment in the AOD, BBV and STI sectors in the 2019 Health Budget.
Lyrica (pregabalin) and mental health
Be aware of some of the harms associated with using Lyrica with other drugs.
Hepatitis C & Prison
‘Hepatitis C and prison’ contains all you need to know now that hep C treatment is available in prisons.
New buprenorphine (Bupe) depot products
All you need to know about new buprenorphine (Bupe) products – what they are and what’s available.
Vein Care Guide
The Vein Care Guide helps people make informed decisions and reduce the risks of drug-related harms.
Overdose Awareness Day: Calls for greater focus on harm reduction
AIVL is calling for a greater focus on key prevention and harm reduction initiatives on International Overdose Awareness Day.
AOD sector urges governments to seize opportunity to make long-lasting reforms
The AOD sector calls on governments to make permanent or expand on reforms introduced during the pandemic.
AIVL World Hepatitis Day Event 2020
Leading drug and infectious disease organisations unite to discuss COVID-19 impact on hepatitis C elimination in Australia on World Hepatitis Day.
The Juice – Information for Safer Gains
Hepatitis Australia/ AIVL joint project ‘The Juice’ is a dedicated resource for people who use performance and image enhancing drugs (PIEDs).
Harm Reduction International Conference postponed to 2023
The HR23 conference will be held in Melbourne in partnership with AIVL and other harm reduction service providers.
International Drug Users Day: UN calls for an end to criminalisation
AIVL is calling on governments to heed calls from the UN for an end to criminalisation on International Drug Users Day.
Podcast
AIVL Podcasts showcase the work of our member organisations by interviewing peer workers about their roles and the work they do. The podcasts provide a unique insight into the individual perspectives of peer workers in AIVL member organisations across the country, as well as providing information on particular projects and activities of relevance to the work of AIVL’s National Peer …
Introduction to AIVL and its member organisations
Find out about AIVL’s member organisations around Australia and what they do.
Codeine factsheet
From 1 February 2018, medicines containing codeine will no longer be available without a prescription.
Government defies logic on welfare drug testing
The Social Services Legislation Amendment (Drug Testing Trial) Bill 2019 seeks to introduce drug testing for welfare recipients.
Mandatory testing of welfare recipients pointless given absence of treatment services
AIVL has expressed frustration at the revival of Australian Government plans to impose drug testing on welfare recipients.
International Overdose Awareness Day: Calls for greater focus on prevention and harm reduction
AIVL is calling for a greater focus on key prevention and harm reduction initiatives on International Overdose Awareness Day.
Hepatitis C Peer Education Training Module
AIVL has developed a training module to provide education to people living with or at risk of hepatitis C.
Stigma and Discrimination Online Training Module developed
AIVL has developed the ‘A Normal Day’ training module to improve comms between health professionals and people who use illicit drugs.
New BBV/STI & AOD measures feature in Health Budget
AIVL has welcomed additional investments in BBV, STIs and AOD initiatives flagged in tonight’s Federal Budget.
HEP C & YOU
‘Hep C & You’ is a users’ guide to the latest information on treatment, testing and more.
Peer Workforce Capacity Building Training Framework
Peer processes among injecting drug users – Indicators of best practice in peer based and mainstream organisations.
A Normal Day Stigma and Discrimination Training Module
Designed to enhance understanding between people who use drugs and healthcare professionals.
Peak health and community organisations pleased with new national BBV and STI strategies
Peak community organisations today welcomed the release of five new BBV and STI strategies by the Australian Government.
Custodial settings and decriminalisation of sex work feature in new BBV & STI strategies
AIVL and Scarlet Alliance, Australian Sex Workers Association welcome the release of five new BBV and STI strategies.
Broad support for 12 month extension to opt-out period for ‘My Health Record’
AIVL wants to extend the opt-out period for the government’s ‘My Health Record’ by 12 months.
International Drug Users Day
AIVL is calling for a greater focus on key prevention and harm reduction initiatives on International Overdose Awareness Day.
The Being Real Project
‘Being real’ provides a framework for drug user organisations to work with Aboriginal people who use drugs.
Injecting Involves Blood – Be ‘Blood Aware’
Find out where to obtain information on blood borne viruses and how to inject safely.
Needle and Syringe Programs in Australia: Peer-led Best Practice (the Guide)
‘The Guide’ details the needs of people who inject drugs and practice considerations for service providers.
Victorian safe injecting facility announcement
AIVL has welcomed the Victorian Government’s decision to trial a medically supervised injecting room in North Richmond.
International Overdose Awareness Day 2017
AIVL is calling for a greater focus on key prevention and harm reduction initiatives on International Overdose Awareness Day.
CAHMA service community event to mark World Hepatitis Day 2017
CAHMA, The Connection and AIVL are hosting a community event to open CAHMA and The Connection’s new premises in Belconnen.
Report calls for NSPs in prisons to address hepatitis C in Australia
New report from AIVL looks at the needs of people living with Hepatitis C after leaving custodial settings in Australia.
Federal Budget 2018: A good start but more to do on drug support services
AIVL has welcomed more funding for drug treatment in the Budget but is disappointed other harm reduction measures have missed out.
International Overdose Awareness Day 2018
AIVL is calling for a greater focus on key prevention and harm reduction initiatives on International Overdose Awareness Day.
Custodial setting and hepatitis C report released
The report makes recommendations for improving hepatitis C treatment for people within or exiting custodial settings.
Enhancing NSP service delivery
The Enhancing NSP Service Delivery project aims to strengthen Australia’s NSP system through a peer-led best practice framework.
Liver First
This resource offers information to help people minimise risks and make safer choices regarding their liver.
A needs analysis for people living with HCV after leaving custodial settings in Australia
Details the needs of People Living with hepatitis C as they are discharged from custody.
National statement on ethical issues for research involving injecting/illicit drug users
This National Statement is aimed at developing and establishing a set of national ethical standards.